These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8714333)

  • 21. The importance of role models.
    Provet P
    Behav Healthc; 2007 May; 27(5):18-9. PubMed ID: 17958238
    [No Abstract]   [Full Text] [Related]  

  • 22. The contribution of consensus within staff and client groups as well as concordance between staff and clients to treatment engagement.
    Melnick G; Wexler HK; Chaple M; Banks S
    J Subst Abuse Treat; 2006 Oct; 31(3):277-85. PubMed ID: 16996390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment for substance abuse in Australia: a comparison of public and private programs.
    McNeese-Smith DK
    Int J Psychiatr Nurs Res; 2003 Sep; 9(1):1025-38. PubMed ID: 14533233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A rural collaborative model of treatment and recovery services for pregnant and parenting women with dual disorders.
    Ryland SA; Lucas L
    J Psychoactive Drugs; 1996; 28(4):389-95. PubMed ID: 9017559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Residential substance abuse treatment for pregnant and postpartum women and their children: treatment and policy implications.
    Clark HW
    Child Welfare; 2001; 80(2):179-98. PubMed ID: 11291900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fidelity of an outreach treatment program for chronic crack abusers in the Netherlands to the ACT model.
    Henskens R; Garretsen H; Mulder CL; Bongers I; Kroon H
    Psychiatr Serv; 2005 Nov; 56(11):1451-4. PubMed ID: 16282268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The interplay of national, state, and local policy in financing care for drug-affected women and children in California.
    Soman LA; Brindis C; Dunn-Malhotra E
    J Psychoactive Drugs; 1996; 28(1):3-15. PubMed ID: 8714330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An ecological model of maternal substance abuse and child neglect: issues, analyses, and recommendations.
    Cash SJ; Wilke DJ
    Am J Orthopsychiatry; 2003 Oct; 73(4):392-404. PubMed ID: 14609401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival analysis of three treatment modalities in a residential substance abuse program for women and children.
    McComish JF; Greenberg R; Ager J; Chruscial H; Laken MA
    Outcomes Manag Nurs Pract; 2000; 4(2):71-7. PubMed ID: 11111587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substance abuse treatment evolves: a follow-up.
    Spath P
    Hosp Peer Rev; 1997 Sep; 22(9):132-4. PubMed ID: 10173140
    [No Abstract]   [Full Text] [Related]  

  • 31. PAR village. Specialized intervention for cocaine abusing women and their children.
    Coletti SD; Hughes PH; Landress HJ; Neri RL; Sicilian DM; Williams KM; Urmann CF; Anthony JC
    J Fla Med Assoc; 1992 Oct; 79(10):701-5. PubMed ID: 1334119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treating substance-using women and their children in public housing: preliminary evaluation findings.
    Metsch LR; Wolfe HP; Fewell R; McCoy CB; Elwood WN; Wohler-Torres B; Petersen-Baston P; Haskins HV
    Child Welfare; 2001; 80(2):199-220. PubMed ID: 11291901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increasing program capability to provide treatment for co-occurring substance use and mental disorders: organizational characteristics.
    Gotham HJ; Claus RE; Selig K; Homer AL
    J Subst Abuse Treat; 2010 Mar; 38(2):160-9. PubMed ID: 19717273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The success of therapeutic communities for substance abusers in American prisons.
    Wexler HK
    J Psychoactive Drugs; 1995; 27(1):57-66. PubMed ID: 7602441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A decade of drug treatment court research.
    Turner S; Longshore D; Wenzel S; Deschenes E; Greenwood P; Fain T; Harrell A; Morral A; Taxman F; Iguchi M; Greene J; McBride D
    Subst Use Misuse; 2002; 37(12-13):1489-527. PubMed ID: 12487232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implementation of an evidence-based modified therapeutic community: staff and resident perspectives.
    Tuchman E; Sarasohn MK
    Eval Program Plann; 2011 May; 34(2):105-12. PubMed ID: 20800284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mental health improvements of substance-dependent clients after 4 months in a Therapeutic Community.
    Polimeni AM; Moore SM; Gruenert S
    Drug Alcohol Rev; 2010 Sep; 29(5):546-50. PubMed ID: 20887579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measuring client clinical progress in therapeutic community treatment. The therapeutic community Client Assessment Inventory, Client Assessment Summary, and Staff Assessment Summary.
    Kressel D; De Leon G; Palij M; Rubin G
    J Subst Abuse Treat; 2000 Oct; 19(3):267-72. PubMed ID: 11027897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substance misuse: what place for women-only treatment programs?
    Weisner C
    Addiction; 2005 Jan; 100(1):7-8. PubMed ID: 15598183
    [No Abstract]   [Full Text] [Related]  

  • 40. Psychopathology and substance abuse: what is being learned from research in therapeutic communities.
    De Leon G
    J Psychoactive Drugs; 1989; 21(2):177-88. PubMed ID: 2668482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.